Skip to content

Observing the Neurovascular Protective Effect of Stroke-Promoting Moxibustion on Ischemic Stroke Patients Based on Anti-Inflammatory Effects of Vascular Endothelial Cells

Observing the Neurovascular Protective Effect of Stroke-Promoting Moxibustion on Ischemic Stroke Patients Based on Anti-Inflammatory Effects of Vascular Endothelial Cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000284
Enrollment
Unknown
Registered
2026-02-03
Start date
2025-07-02
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

control group:Routine treatment

Sponsors

Wuxi No.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the above diagnostic criteria of traditional Chinese and Western medicine; (2) Aged 20-80 years, regardless of gender; (3) Disease duration between 2 weeks and 6 months; (4) With neurological impairment, clear consciousness, stable signs, and able to cooperate in completing various evaluations; (5) Informed consent to participate in the trial, and those with clear consciousness sign the informed consent form themselves.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria or inclusion criteria; (2) Those with severe disturbance of consciousness, severe dementia, speech disorder, or other conditions that make it impossible to communicate and describe their condition; (3) Those with complicated severe abnormalities of heart, lung, liver, kidney or other organ functions, or in the acute stage of other serious diseases; (4) Those who cannot cooperate as required and have poor compliance; (5) Those who are allergic to moxibustion, or are afraid of or intolerant to acupuncture and moxibustion; (6) Those who are participating in other clinical trials; (7) Those who are lost during the treatment process; Anyone who meets any of the above conditions will be excluded.

Design outcomes

Primary

MeasureTime frame
Cerebral circulation indicators;

Secondary

MeasureTime frame
NIHSS scale;ADL scale;IL-6;NF-?B;ET-1;eNOS;

Countries

China

Contacts

Public ContactShen Cuicui

Wuxi No.2 People's Hospital

scc128@sina.com+86 150 5068 7936

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026